SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-020244
Filing Date
2024-05-16
Accepted
2024-05-16 16:16:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 269004
2 form424b3_001.jpg GRAPHIC 3265
3 form424b3_002.jpg GRAPHIC 11685
  Complete submission text file 0001493152-24-020244.txt   291100
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-279095 | Film No.: 24955828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)